Skip to content
Discussion options

You must be logged in to vote

Hi, Sorry for answering so late.
But I don't think your fraction absorbed of 2.11 is a limitation of PK-Sim. It just tells you that your compound molecules are absorbed more than once due to your EHC assumption. And it is quite physiological to assume that in case of enterohepatic cycling you have a reuptake of excreted compound. It might prompt you to think about your assumption. I am not sure if EHC has been found for Glipizide? Is your compound a substrate for bilary transporters?
You might think of other possible explanation for double peaks. E.g. check this out https://doi.org/10.1208/s12248-020-00548-8 and look at figure 3. Nefadozone-HCl. Pepin et al could rule out EHC and discuss …

Replies: 1 comment

Comment options

You must be logged in to vote
0 replies
Answer selected by hjhj112233
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
2 participants